AEON Biopharma, Inc. (AEON) vs Passage Bio, Inc. (PASG)

AEON Biopharma, Inc. and Passage Bio, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Passage Bio, Inc. are of similar size ($12.1M and $11.6M). Across the 7 metrics below, Passage Bio, Inc. leads on 4 and AEON Biopharma, Inc. on 3.

Valuation

Metric AEON PASG Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 2.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.34 0.64
EV/Sales n/m n/m 9.21
Earnings yield (1,921.74%) (325.29%) (33.15%)
Free cash flow yield (117.41%) (326.67%) (25.50%)

Profitability

Metric AEON PASG Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 350.00% (169.09%) (56.36%)
Return on assets (621.70%) (69.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON PASG Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (105.42%) 32.94% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.54 1.22 4.72
Net debt to EBITDA (2.48) 0.96 0.96

Dividend

Metric AEON PASG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AEON PASG Biotechnology median
Market cap 12.12m 11.59m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack